Effect of dipeptidyl peptidase Ⅳ inhibitor on human T cell migration <italic style="font-style: italic">in vitro</italic>

Yunfan CHEN; Junjie SHEN; Cheng QIAN

doi:10.16016/j.1000-5404.201802025

您当前的位置：

首页 >

文章列表页 >

Effect of dipeptidyl peptidase Ⅳ inhibitor on human T cell migration in vitro

更新时间：2026-01-09

- Effect of dipeptidyl peptidase Ⅳ inhibitor on human T cell migration in vitro
- Journal of Third Military Medical University Vol. 40, Issue 16, Pages: 1450-1455(2018)
- 作者机构：
- 作者简介：
- 基金信息：
  
  the National Key Research and Development Program(2016YFC1303405);the Bio-Strategic Innovation Program of First Affiliated Hospital of Third Military Medical University(SWH2016LCYB-06)
- DOI：10.16016/j.1000-5404.201802025
  CLC：
- Received：04 February 2018，
  
  Published：30 August 2018
- 稿件说明：
移动端阅览
Yunfan CHEN, Junjie SHEN, Cheng QIAN. Effect of dipeptidyl peptidase Ⅳ inhibitor on human T cell migration in vitro[J]. Journal of Third Military Medical University, 2018, 40(16): 1450-1455.
DOI：

Yunfan CHEN, Junjie SHEN, Cheng QIAN. Effect of dipeptidyl peptidase Ⅳ inhibitor on human T cell migration in vitro[J]. Journal of Third Military Medical University, 2018, 40(16): 1450-1455. DOI： 10.16016/j.1000-5404.201802025.

摘要

Abstract

Objective

To explore the effect of dipeptidyl peptidase Ⅳ (DPP Ⅳ) inhibitor on human T cell migration

in vitro

Methods

Flow cytometry was used to detect the expression of CXCR3 in human peripheral T cells from healthy donors.The expression of DPP Ⅳ and CXCL10 in colon cancer LoVo cell line was detected with ELISA.Molecular cloning technique were used to construct LoVo cell lines expressing full-length and DPP Ⅳ-truncated CXCL10 [termed LoVo-CXCL10(1-77) and LoVo-CXCL10(3-77)

respectively].The migration of T cells in response to LoVo cells expressing different forms of CXCL10 and the effect of DPP Ⅳ inhibitor on T cell migration were tested with Transwell assay.

Results

CXCR3 was expressed up to 95% on the surface of activated T cells.LoVo cells expressed DPP Ⅳ at a level as high as 1 956.5±95.6 pg/mL but had a low expression level of CXCL10 of 15.5±0.8 pg/mL.The number of migrating T cells in response to LoVo-CXCL10(1-77) cells reached (9.5±0.9)×10

significantly higher than the number of T cells attracted by LoVo-CXCL10(3-77) cells.DPP Ⅳ inhibitor significantly increased the migration of T cells in response to LoVo-CXCL10(1-77) to the level of (12.3±0.9)×10

Conclusion

DPP Ⅳ inhibits the chemotaxis of T cells to CXCL10

in vitro

and DPP Ⅳ inhibitor can enhance the migration of T cells toward tumor cells.

关键词

Keywords

references

BREMNES R M AL-SHIBLI K DONNEM T The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis:emphasis on non-small cell lung cancer J Thorac Oncol 2011 6 4 824 833 10.1097/JTO.0b013e3182037b76 BREMNES R M, AL-SHIBLI K, DONNEM T, et al .The role of tumor- infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis:emphasis on non-small cell lung cancer[J ] .J Thorac Oncol, 2011, 6(4):824-833.DOI:10.1097/JTO.0b013e3182037b76.

NUNES C WONG R MASON M Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression Clin Cancer Res 2012 18 3 678 687 10.1158/1078-0432.CCR-11-2630 NUNES C, WONG R, MASON M, et al .Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression[J ] .Clin Cancer Res, 2012, 18(3):678-687.DOI:10.1158/1078- 0432.CCR-11-2630.

PAGÈS F GALON J DIEU-NOSJEAN M C Immune infiltration in human tumors:a prognostic factor that should not be ignored Oncogene 2010 29 8 1093 1102 10.1038/onc.2009.416 PAGÈS F, GALON J, DIEU-NOSJEAN M C, et al .Immune infiltration in human tumors:a prognostic factor that should not be ignored[J ] .Oncogene, 2010, 29(8):1093-1102.DOI:10.1038/onc.2009.416.

GALON J COSTES A SANCHEZ-CABO F Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 2006 313 5795 1960 1964 10.1126/science.1129139 GALON J, COSTES A, SANCHEZ-CABO F, et al .Type, density, and location of immune cells within human colorectal tumors predict clinical outcome[J ] .Science, 2006, 313(5795):1960-1964.DOI:10.1126/science.1129139.

HARLIN H MENG Y PETERSON A C Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment Cancer Res 2009 69 7 3077 3085 10.1158/0008-5472.CAN-08-2281 HARLIN H, MENG Y, PETERSON A C, et al .Chemokine expression in melanoma met astases associated with CD8+ T-cell recruitment[J ] .Cancer Res, 2009, 69(7):3077-3085.DOI:10.1158/0008-5472.CAN-08-2281.

MLECNIK B TOSOLINI M CHAROENTONG P Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer Gastroenterology 2010 138 4 1429 1440 10.1053/j.gastro.2009.10.057 MLECNIK B, TOSOLINI M, CHAROENTONG P, et al .Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer[J ] .Gastroenterology, 2010, 138(4):1429-1440.DOI:10.1053/j.gastro.2009.10.057.

MIKUCKI M E FISHER D T MATSUZAKI J Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints Nat Commun 2015 6 7458 10.1038/ncomms8458 MIKUCKI M E, FISHER D T, MATSUZAKI J, et al .Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell traffickin g across tumour vascular checkpoints[J ] .Nat Commun, 2015, 6:7458.DOI:10.1038/ ncomms8458.

YU D M YAO T W CHOWDHURY S The dipeptidyl peptidase Ⅳ family in cancer and cell biology FEBS J 2010 277 5 1126 1144 10.1111/j.1742-4658.2009.07526.x YU D M, YAO T W, CHOWDHURY S, et al .The dipeptidyl peptidase Ⅳ family in cancer and cell biology[J ] .FEBS J, 2010, 277(5):1126-1144.DOI:10.1111/j.1742-4658.2009.07526.x.

BECKENKAMP A DAVIES S WILLIG J B DPPIV/CD26:a tumor suppressor or a marker of malignancy Tumour Biol 2016 37 6 7059 7073 10.1007/s13277-016-5005-2 BECKENKAMP A, DAVIES S, WILLIG J B, et al .DPPIV/CD26:a tumor suppressor or a marker of malignancy[J ] .Tumour Biol, 2016, 37(6):7059-7073.DOI:10.1007/s13277-016-5005-2.

OHNUMA K TAKAHASHI N YAMOCHI T Role of CD26/dipeptidyl peptidase Ⅳ in human T cell activation and function Front Biosci 2008 13 2299 2310 10.2741/2844 OHNUMA K, TAKAHASHI N, YAMOCHI T, et al .Role of CD26/dipeptidyl peptidase Ⅳ in human T cell activation and function[J ] .Front Biosci, 2008, 13:2299-2310.DOI:10.2741/2844.

DEACON C F Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes:a comparative review Diabetes Obes Metab 2011 13 1 7 18 10.1111/j.1463-1326.2010.01306.x DEACON C F.Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes:a comparative review[J].Diabetes Obes Metab, 2011, 13(1):7-18.DOI:10.1111/j.1463-1326.2010.01306.x.

MILLER S ST ONGE E L Sitagliptin:a dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes Ann Pharmacother 2006 40 7-8 1336 1343 10.1345/aph.1G665 MILLER S, ST ONGE E L.Sitagliptin:a dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes[J].Ann Pharmacother, 2006, 40(7-8):1336-1343.DOI:10.1345/aph.1G665.

MULVIHILL E E DRUCKER D J Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors Endocr Rev 2014 35 6 992 1019 10.1210/er.2014-1035 MULVIHILL E E, DRUCKER D J.Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors[J].Endocr Rev, 2014, 35(6):992-1019.DOI:10.1210/er.2014-1035.

DE CHIARA L RODRÍGUEZ-PIÑEIRO A M RODRÍGUEZ-BERROCAL F J Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas BMC Cancer 2010 10 333 10.1186/1471-2407-10-333 DE CHIARA L, RODRÍGUEZ-PIÑEIRO A M, RODRÍGUEZ- BERROCAL F J, et al .Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas[J ] .BMC Cancer, 2010, 10:333.DOI:10.1186/1471-2407-10-333.

LAM C S CHEUNG A H WONG S K Prognostic significance of CD26 in patients with colorectal cancer PLoS ONE 2014 9 5 e98582 10.1371/journal.pone.0098582 LAM C S, CHEUNG A H, WONG S K, et al .Prognostic significance of CD26 in patients with colorectal cancer[J ] .PLoS ONE, 2014, 9(5):e98582.DOI:10.1371/journal.pone.0098582.

YANG Y Cancer immunotherapy:harnessing the immune system to battle cancer J Clin Invest 2015 125 9 3335 3337 10.1172/JCI83871 YANG Y.Cancer immunotherapy:harnessing the immune system to battle cancer[J].J Clin Invest, 2015, 125(9):3335-3337.DOI:10.1172/ JCI83871.

CHOW M T LUSTER A D Chemokines in cancer Cancer Immunol Res 2014 2 12 1125 1131 10.1158/2326-6066.CIR-14-0160 CHOW M T, LUSTER A D.Chemokines in cancer[J].Cancer Immunol Res, 2014, 2(12):1125-1131.DOI:10.1158/2326-6066.CIR-14- 0160.

FRANCISZKIEWICZ K BOISSONNAS A BOUTET M Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response Cancer Res 2012 72 24 6325 6332 10.1158/0008-5472.CAN-12-2027 FRANCISZKIEWICZ K, BOISSONNAS A, BOUTET M, et al .Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response[J ] .Cancer Res, 2012, 72(24):6325-6332.DOI:10.1158/0008-5472.CAN-12-2027.

NASSER M W ELBAZ M AHIRWAR D K Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins Cancer Lett 2015 365 1 11 22 10.1016/j.canlet.2015.05.002 NASSER M W, ELBAZ M, AHIRWAR D K, et al .Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins[J ] .Cancer Lett, 2015, 365(1):11-22.DOI:10.1016/j.canlet.2015.05.002.

SARVAIYA P J GUO D ULASOV I Chemokines in tumor progression and metastasis Oncotarget 2013 4 12 2171 2185 10.18632/oncotarget.1426 SARVAIYA P J, GUO D, ULASOV I, et al .Chemokines in tumor progression and metastasis[J ] .Oncotarget, 2013, 4(12):2171-2185.DOI:10.18632/oncotarget.1426.

CASROUGE A BISIAUX A STEPHEN L Discrimination of agonist and antagonist forms of CXCL10 in biological samples Clin Exp Immunol 2012 167 1 137 148 10.1111/j.1365-2249.2011.04488.x CASROUGE A, BISIAUX A, STEPHEN L, et al .Discrimination of agonist and antagonist forms of CXCL10 in biological samples[J ] .Clin Exp Immunol, 2012, 167(1):137-148.DOI:10.1111/ j.1365-2249.2011.04488.x.

MORTIER A GOUWY M VAN DAMME J Effect of posttranslational processing on the in vitro and in vivo activity of chemokines Exp Cell Res 2011 317 5 642 654 10.1016/j.yexcr.2010.11.016 MORTIER A, GOUWY M, VAN DAMME J, et al .Effect of posttranslational processing on the in vitro and in vivo activity of chemokines[J ] .Exp Cell Res, 2011, 317(5):642-654.DOI:10.1016/ j.yexcr.2010.11.016.

KARAGIANNIS T BOURA P TSAPAS A Safety of dipeptidyl peptidase 4 inhibitors:a perspective review Ther Adv Drug Saf 2014 5 3 138 146 10.1177/2042098614523031 KARAGIANNIS T, BOURA P, TSAPAS A.Safety of dipeptidyl peptidase 4 inhibitors:a perspective review[J].Ther Adv Drug Saf, 2014, 5(3):138-146.DOI:10.1177/2042098614523031.

ANZ D KRUGER S HAUBNER S The dipeptidylpeptidase-Ⅳ inhibitors sitagliptin, vildagliptin and saxagliptin do not impair innate and adaptive immune responses Diabetes Obes Metab 2014 16 6 569 572 10.1111/dom.12246 ANZ D, KRUGER S, HAUBNER S, et al .The dipeptidylpeptidase-Ⅳ inhibitors sitagliptin, vildagliptin and saxagliptin do not impair innate and adaptive immune responses[J ] .Diabetes Obes Metab, 2014, 16(6):569-572.DOI:10.1111/dom.12246.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Heterogeneity of epithelial-mesenchymal transition and CD26 expression in hypertrophic scars and keloids

Stathmin mediates TNF-α-induced skin fibroblast migration by promoting formation of filopodia

Bone marrow mesenchymal stem cell-derived exosomes promote proliferation, invasion and migration of renal cancer cells by regulating cholestanol metabolism

UHRF2 promotes migration and proliferation of human hepatocellular carcinoma cells by PI3K/Akt signaling pathway

Effects of exosomes derived from placental mesenchymal stem cells on high glucose-induced senescence in human dermal fibroblasts

Related Author

Wanru GONG

Mengchang LIU

Xingke LIU

Defu XIE

Hong YAN

Ruiyan CEN

Lingfei LI

Yumeng DENG

Related Institution

Department of Plastic and Burn Surgery, National Key Clinical Construction Specialty, Wound Repair and Regeneration Laboratory, Affiliated Hospital of Southwest Medical University

Department of Dermatology, Army Medical Center of PLA

Department of Urology, the First Affiliated Hospital of Chongqing Medical University

Department of Hepatobillary Surgery, the First Affiliated Hospital of Chongqing Medical University

Department of Cell Biology and Genetics, Molecular Medicine and Cancer Research Center, College of Basic Medical Sciences, Chongqing Medical University

⁰

Effect of dipeptidyl peptidase Ⅳ inhibitor on human T cell migration in vitro

DOI：10.16016/j.1000-5404.201802025

摘要

Abstract

关键词

Keywords

references